Profiel
Peter H.
Seeberger was the founder of i2chem, Inc. (2005) and Synglyco, Inc. (2001) where the title held was Director from 2009 to 2010.
Dr. Seeberger is also the founder of TACALYX GmbH.
Current jobs include Director at Tesfa-ilg Stiftung, Professor at Freie Universität Berlin, and Professor at Max Planck Institute of Colloids & Interfaces.
Former jobs include Professor at Massachusetts Institute of Technology from 2002 to 2010, Professor at Swiss Federal Institute of Technology, and Affiliate Professor at Sanford Burnham Prebys Medical Discovery Institute.
Education includes a doctorate from The University of Colorado, conferred in 1995.
Actieve functies van Peter H. Seeberger
| Bedrijven | Functie | Begin |
|---|---|---|
Tesfa-ilg Stiftung | Directeur/Bestuurslid | - |
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Max Planck Institute of Colloids & Interfaces
Max Planck Institute of Colloids & Interfaces Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
TACALYX GmbH
TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services Develops therapeutics targeting cancer-specific carbohydrate antigens for metastatic malignant tumors | Oprichter | - |
Eerdere bekende functies van Peter H. Seeberger
| Bedrijven | Functie | Einde |
|---|---|---|
i2chem, Inc.
i2chem, Inc. SemiconductorsElectronic Technology Manufactures pharmaceutical products | Oprichter | - |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Conducts medical research | Corporate Officer/Principal | - |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | - |
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Oprichter | - |
Opleiding van Peter H. Seeberger
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Conducts medical research | Health Services |
i2chem, Inc.
i2chem, Inc. SemiconductorsElectronic Technology Manufactures pharmaceutical products | Electronic Technology |
Max Planck Institute of Colloids & Interfaces
Max Planck Institute of Colloids & Interfaces Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tesfa-ilg Stiftung | |
TACALYX GmbH
TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services Develops therapeutics targeting cancer-specific carbohydrate antigens for metastatic malignant tumors | Commercial Services |
















